October 27, 2009 (FinancialWire) — Inovio Biomedical Corp.’s (AMEX: INO) (Current Market Cap: $123.19 Mil.) board has elected David J. Williams and Keith H. Wells as directors.

Williams is the former chairman and CEO of Sanofi Pasteur, the vaccine business of Sanofi-Aventis Group. Wells is a senior member of the Biologics Consulting Group and former director of vaccine development for The Salk Institute.

San Diego-based Inovio Biomedical is focused on the design, development, and delivery of a new generation of vaccines, called DNA vaccines, to prevent and treat cancers and infectious diseases.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.